Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Immunic (IMUX) stocks in Canada

Learn how to easily invest in Immunic stocks.

Immunic is a biotechnology business based in the US. Immunic stocks (IMUX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $13.1 – an increase of 4.11% over the previous week. Immunic employs 52 staff and has a market cap (total outstanding stock value) of $278.8 million.

How to buy shares in Immunic

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IMUX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Immunic stock price (NASDAQ:IMUX)

Use our graph to track the performance of IMUX stocks over time.

Immunic shares at a glance

Information last updated 2022-01-25.
Latest market close$10.88
52-week range$6.96 - $28.21
50-day moving average $9.67
200-day moving average $10.73
Wall St. target price$54.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.88

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Immunic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Immunic price performance over time

Historical closes compared with the close of $10.88 from 2022-01-26

1 week (2022-01-19) -3.80%
1 month (2021-12-27) 13.69%
3 months (2021-10-28) 18.39%
6 months (2021-07-28) 18.91%
1 year (2021-01-28) -34.93%
2 years (2020-01-27) 35.49%
3 years (2019-01-25) 5,080.95%
5 years (2017-01-27) 115.45%

Immunic financials

Gross profit TTM $0
Return on assets TTM -25.46%
Return on equity TTM -53.78%
Profit margin 0%
Book value $5.54
Market capitalisation $278.8 million

TTM: trailing 12 months

Immunic share dividends

We're not expecting Immunic to pay a dividend over the next 12 months.

Have Immunic's shares ever split?

Immunic's shares were split on a 1:40 basis on 14 April 2019. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Immunic shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Immunic shares which in turn could have impacted Immunic's share price.

Immunic share price volatility

Over the last 12 months, Immunic's shares have ranged in value from as little as $6.96 up to $28.214. A popular way to gauge a stock's volatility is its "beta".

IMUX.US volatility(beta: 1.94)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immunic's is 1.9362. This would suggest that Immunic's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Immunic overview

Immunic, Inc. , a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York. .

Stocks similar to Immunic

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site